These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 12954520)

  • 21. [Misoprostol: off-label use in the first trimester of pregnancy (spontaneous abortion, and voluntary medical termination of pregnancy)].
    Beucher G; Dolley P; Carles G; Salaun F; Asselin I; Dreyfus M
    J Gynecol Obstet Biol Reprod (Paris); 2014 Feb; 43(2):123-45. PubMed ID: 24433988
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Early abortion with buccal versus sublingual misoprostol alone: a multicenter, randomized trial.
    Sheldon WR; Durocher J; Dzuba IG; Sayette H; Martin R; Velasco MC; Winikoff B
    Contraception; 2019 May; 99(5):272-277. PubMed ID: 30831103
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Vaginal misoprostol for pre-abortion cervical priming: is there an optimal evacuation time interval?
    Singh K; Fong YF; Prasad RN; Dong F
    Br J Obstet Gynaecol; 1999 Mar; 106(3):266-9. PubMed ID: 10426647
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Use of mifepristone and sublingual misoprostol for early medical abortion.
    Lin M; Li YT; Chen FM; Wu SF; Tsai CW; Chen TH; Kuo TC
    Taiwan J Obstet Gynecol; 2006 Dec; 45(4):321-4. PubMed ID: 17175490
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Pilot study on the use of a two-week course of oral misoprostol in patients after termination of pregnancy with mifepristone and misoprostol.
    Tang OS; Gao PP; Cheng L; Lee S; Ho PC
    Contraception; 1998 Feb; 57(2):89-91. PubMed ID: 9589834
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A randomised comparative study on sublingual versus vaginal administration of misoprostol for termination of pregnancy between 13 to 20 weeks.
    Bhattacharjee N; Saha SP; Ghoshroy SC; Bhowmik S; Barui G
    Aust N Z J Obstet Gynaecol; 2008 Apr; 48(2):165-71. PubMed ID: 18366490
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Mifepristone and vaginal misoprostol on the same day for abortion from 50 to 63 days' gestation.
    Fox MC; Creinin MD; Harwood B
    Contraception; 2002 Oct; 66(4):225-9. PubMed ID: 12413616
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Vaginal misoprostol compared with vaginal gemeprost in termination of second trimester pregnancy. A randomized trial.
    Wong KS; Ngai CS; Wong AY; Tang LC; Ho PC
    Contraception; 1998 Oct; 58(4):207-10. PubMed ID: 9866000
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A prospective randomised comparison of sublingual and vaginal misoprostol in second trimester termination of pregnancy.
    Tang OS; Lau WN; Chan CC; Ho PC
    BJOG; 2004 Sep; 111(9):1001-5. PubMed ID: 15327617
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A comparative study on sublingual versus oral and vaginal administration of misoprostol for late first and early second trimester abortion.
    Ganguly RP; Saha SP; Mukhopadhyay S; Bhattacharjee N; Bhattacharyya SK; Patra KK
    J Indian Med Assoc; 2010 May; 108(5):283-4, 286. PubMed ID: 21121402
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Home self-administration of vaginal misoprostol for medical abortion at 50-63 days compared with gestation of below 50 days.
    Kopp Kallner H; Fiala C; Stephansson O; Gemzell-Danielsson K
    Hum Reprod; 2010 May; 25(5):1153-7. PubMed ID: 20172871
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Termination of pregnancy at 9-13 weeks' amenorrhoea with mifepristone and misoprostol.
    Ashok PW; Flett GM; Templeton A
    Lancet; 1998 Aug; 352(9127):542-3. PubMed ID: 9716062
    [TBL] [Abstract][Full Text] [Related]  

  • 33. First-trimester pregnancy termination with 800 microg of vaginal misoprostol every 12 h.
    Salakos N; Kountouris A; Botsis D; Rizos D; Gregoriou O; Detsis G; Creatsas G
    Eur J Contracept Reprod Health Care; 2005 Dec; 10(4):249-54. PubMed ID: 16448952
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Sublingual misoprostol 100 microgram versus 200 microgram for second trimester abortion: a randomised trial.
    Caliskan E; Doger E; Cakiroglu Y; Corakci A; Yucesoy I
    Eur J Contracept Reprod Health Care; 2009 Feb; 14(1):55-60. PubMed ID: 19241302
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A comparison of the efficacy of sublingual and oral misoprostol 400 microgram in the management of early pregnancy failure: a randomized controlled trial.
    Ayudhaya OP; Herabutya Y; Chanrachakul B; Ayuthaya NI; O-Prasertsawat P
    J Med Assoc Thai; 2006 Oct; 89 Suppl 4():S5-10. PubMed ID: 17726806
    [TBL] [Abstract][Full Text] [Related]  

  • 36. First trimester abortion with mifepristone and three doses of sublingual misoprostol: a pilot study.
    Singh KC; Ummat S; Rajaram S; Goel N
    Aust N Z J Obstet Gynaecol; 2005 Dec; 45(6):495-8. PubMed ID: 16401215
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Efficacy of methotrexate and misoprostol for early abortion.
    Ozeren S; Corakçi A; Yücesoy I; Mercan R; Arslan A; Erhan G
    Gynecol Obstet Invest; 1997; 44(2):112-4. PubMed ID: 9286724
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A prospective double-blinded, randomized, placebo-controlled trial on the use of letrozole pretreatment with misoprostol for second-trimester medical abortion.
    Lee VC; Tang OS; Ng EH; Yeung WS; Ho PC
    Contraception; 2011 Dec; 84(6):628-33. PubMed ID: 22078193
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Comparison of vaginal and sublingual misoprostol for second trimester abortion: randomized controlled equivalence trial.
    von Hertzen H; Piaggio G; Wojdyla D; Nguyen TM; Marions L; Okoev G; Khomassuridze A; Kereszturi A; Mittal S; Nair R; Daver R; Pretnar-Darovec A; Dickson K; Nguyen DH; Nguyen HB; Hoang TD; Peregoudov A;
    Hum Reprod; 2009 Jan; 24(1):106-12. PubMed ID: 18794161
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Increasing women's choices in medical abortion: a study of misoprostol 400 microg swallowed immediately or held sublingually following 200 mg mifepristone.
    Akin A; Dabash R; Dilbaz B; Aktün H; Dursun P; Kiran S; Aksan G; Doğan B; Winikoff B
    Eur J Contracept Reprod Health Care; 2009 Jun; 14(3):169-75. PubMed ID: 19565414
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.